Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a type of kidney cancer called Renal Cell Carcinoma (RCC), either as an individual or together with their partner or spouse
- Partners or spouses of kidney cancer patients who meet the criteria for this trial
- Patients who have had surgery to remove a localised kidney tumour (categorised by doctors as T1, T2, or T3 stage)
- For Phase 1 only: patients whose surgery took place anywhere between just after the operation and up to 10 years ago
- People who can speak, read, and write in Danish
- For Phase 1: people who are able and willing to attend meetings either online or in person at Gødstrup Hospital
- For Phase 2: people who are able to receive digital communications from the hospital
- For Phase 2: people who are willing to sign a consent form before answering questions about fear of cancer coming back
Who may not be able to join:
- People who have been diagnosed with a cognitive impairment (a condition affecting memory, thinking, or understanding)
- People who have an untreated psychiatric or mental health condition, as this may affect participation
- For Phase 2 only: people who already took part as panel members in Phase 1 of this trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Brigitta R Villumsen, PhD, Gødstrup Hospital
Phone: +45 20487820
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Phase 1: Assessment of the recruitment to and composition the patient-partner panel; Phase 1: Assessment of the degree of patient and partner/spouse involvement; Phase 2: To investigate whether the recommendations for timing, instructions, mode of administration and Fear of Cancer Recurrence questions stated in phase 1 are feasible in a clinical setting,; Phase 2: The prevalence of Fear of Cancer Recurrence in single patients with localized Renal Cell Carcinoma; Phase 2: The prevalence of Fear of Cancer Recurrence in patients with localized Renal Cell Carcinoma and living in a relationship wit...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.